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Abstract
Objectives—To ascertain, through two separate surveys among nationally representative 
networks of pediatricians (Peds) and family physicians (FM): 1) physicians’ reported level of 
confidence in pre- and post-licensure vaccine safety studies; and 2) changes in reported level of 
confidence from 2007 to 2010/11.
Methods—Two surveys were conducted in August to October 2007 and in November 2010 to 
January 2011. The survey response rates were 81% (FM, 79%, Peds, 84%, p=0.07) for the 2007 
survey (691/848) and 66% (FM, 61%, Peds, 70%, p=0.003) for the 2010/11 survey (532/811).
Results—One in three family physicians compared to one in ten pediatricians in both surveys 
reported little or no confidence in pre-licensure vaccine safety studies (p<0.001). Compared to 
pre-licensure studies, higher percentages of both specialties reported a great deal of confidence in 
post-licensure vaccine safety studies in both years, and more physicians from both specialties 
reported a great deal of confidence in 2010/11 than in 2007.
Conclusion—While most family physicians and pediatricians report confidence in post-
licensure vaccine safety studies, one third of family physicians report little or no confidence in 
pre-licensure studies. More research is needed to better understand the reasons behind some 
physicians’ lack of confidence in vaccine safety studies.
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The United States has an elaborate system for assessing vaccine safety (Salmon et al., 2011). 
Vaccines undergo extensive testing prior to approval to assess immunogenicity, efficacy, 
and safety. Rare adverse events, however, are difficult to detect pre-licensure (Jacobson et 
al., 2001). Because of this, the Centers for Disease Control and Prevention and others have 
developed systems for post-licensure vaccine safety monitoring, including the Vaccine 
Adverse Event Reporting System (Varricchio et al., 2004) and the Vaccine Safety Datalink 
(Baggs et al., 2011; Chen et al., 2000). Since 2005, there have been nine new vaccines 
introduced into the child and adolescent immunization schedule including two rotavirus 
vaccines, two meningococcal conjugate vaccines, two human papillomavirus vaccines, two 
tetanus–diphtheria–acellular pertussis vaccines, and a 13-valent pneumococcal conjugate 
vaccine. There have also been several new combination vaccines introduced.
As the perception of vaccine hesitancy among parents appears to be on the rise (Kempe et 
al., 2011), there is growing concern among vaccine advocates regarding effective ways to 
communicate accurate vaccine safety information to the public (Kennedy et al., 2011). A 
child’s physician, however, has consistently been shown to be the most trusted source of 
information about vaccines among parents (Benin et al., 2006; Freed et al., 2010; Gellin et 
al., 2000). The level of confidence that physicians themselves have in vaccine safety studies 
is therefore important to gauge, but is currently unknown. The objectives of this study were 
to ascertain, through two separate surveys among nationally representative networks of 
pediatricians and family physicians: 1) physicians’ reported level of confidence in pre- and 
post-licensure vaccine safety studies; and 2) changes in reported level of confidence from 
2007 to 2010/11.
Methods
Two national surveys were conducted August to October 2007 and November 2010 to 
January 2011 using two distinct physician survey networks designed to be representative of 
the American Academy of Family Physicians (AAFP) and American Academy of Pediatrics 
(AAP) memberships. These networks are similar to physicians randomly sampled from the 
American Medical Association master file with respect to demographics and vaccine-related 
attitudes (Crane et al., 2008). The human subjects review board at the University of 
Colorado Denver approved this study.
The questions assessed physicians’ confidence in pre- and post-licensure vaccine safety 
studies using 4-point Likert scales and were embedded in larger surveys regarding rotavirus 
vaccine. Physicians were asked “How much confidence do you have in pre-licensure studies 
(prior to FDA approval) in determining vaccine safety?” and “How much confidence do you 
have in the post-licensure surveillance (VAERS and other safety mechanisms) to monitor 
vaccine safety?” The surveys were pretested by physician advisory boards and pilot tested in 
national samples of primary care physicians (Varricchio et al., 2004). They were 
administered via mail or Internet (Vovici, Dulles, VA) using a tailored approach (Dillman et 
al., 2009).
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Tests for association with the primary outcome of reporting little or no confidence in pre-
licensure vaccine safety studies were performed on both survey populations of family 
physicians using chi-square analyses. Factors significant at p<0.25 in bivariate analyses 
were tested in multivariable models, and only factors that were significant at p<0.05 were 
retained in the final model. Similar analyses were not performed for pediatricians, because 
their rate of responding ‘little or no confidence’ was so low.
The survey response rates were 81% (FM, 79%, Peds, 84%, p=0.07) for the 2007 survey 
(691/848) and 66% (FM, 61%, Peds, 70%, p=0.003) for the 2010/11 survey (532/811). 
Survey populations are shown in Tables 2–4, online supplementary material.
Results
While most respondents overall reported a great deal or moderate confidence in pre-
licensure vaccine safety studies in both 2007 and 2010/11, approximately one-third of 
family physicians reported little or no confidence in both years (Table 1). Compared to pre-
licensure studies, higher percentages of both specialties reported a great deal of confidence 
in post-licensure vaccine safety studies in both years, and more physicians reported a great 
deal of confidence in 2010/11 than in 2007. For all comparisons, pediatricians were more 
likely than family physicians to report a great deal or moderate confidence and less likely to 
report little or no confidence (p<0.001). In both bivariate and multivariable analyses among 
family physicians (Tables 5–6, online supplemental material), only practice location was 
associated with reporting little or no confidence in pre-licensure vaccine safety studies in the 
2007 survey, with respondents practicing in a non-inner-city/suburban environment more 
likely to report ‘little or no confidence’ than those practicing in urban/inner city or rural 
settings (p=0.03). In 2010, the only associated factor was a practice setting of community/
hospital-based/managed care organization vs. private practice (p=0.03).
Discussion
Our study using national networks of primary care physicians found that confidence in post-
licensure vaccine safety studies increased from 2007 to 2010/11, but that confidence in pre-
licensure studies remained unchanged. Our data suggest that pediatricians have more 
confidence in vaccine safety studies compared to family physicians.
Many physicians report a great deal of confidence in post-licensure vaccine safety studies, 
and this appears to be increasing. There are several potential reasons for this high level of 
confidence. Though adverse events are rare, post-licensure studies have successfully 
identified potential vaccine-associated events (Klein et al., 2010; France et al., 2008; 
O’Leary et al., 2012), the most notable of which was the withdrawal of the rhesus-based 
rotavirus vaccine (RotaShield, Wyeth-Lederle) 11 months after licensure after detection of a 
slightly increased risk of intussusception after the first dose (McPhillips et al., 2001; Murphy 
et al., 2001). It is also possible that awareness of post-licensure safety monitoring following 
the introduction of the newer rotavirus vaccines influenced physicians’ reported level of 
confidence in post-licensure studies, particularly since these questions were asked in the 
context of larger rotavirus vaccine surveys.
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It is unclear why one-third of family physicians report little or no confidence in pre-
licensure vaccine safety studies. While pre-licensure studies did not detect the slightly 
increased risk of intussusception after RotaShield, since that time pre-licensure studies have 
had remarkable concordance with post-licensure studies in the US. Family physicians’ lower 
confidence in pre-licensure vaccine safety studies may be one factor that helps explain why 
family physicians in general adopt new childhood vaccines more slowly than pediatricians 
(Davis et al., 2003; Kempe et al., 2009).
This study has important strengths and limitations. To our knowledge, it is the only study in 
the last 10 years to directly assess physicians’ confidence in vaccine safety studies, and the 
only one to make a longitudinal comparison. The surveyed physicians are generally 
representative of members of the AAP and the AAFP (Crane et al., 2008), and although 
there was a notable difference in response rates from 2007 to 2010/11, the response rates 
were high. However, respondents may have differed from non-respondents. In addition, the 
response rates were lower for family physicians than for pediatricians which may limit the 
validity of the comparison between specialties. Also, although the questions in the survey 
were asked generically about safety studies in general, they were asked in the context of a 
larger rotavirus survey which may have influenced physicians’ responses.
As pediatricians and family physicians deliver most vaccines to children in the US, their 
confidence in the safety of new vaccines is crucial to the ongoing success of our national 
immunization program and delays in adoption of new vaccines could have important 
consequences. While most physicians report confidence in post-licensure vaccine safety 
studies, if many physicians are not confident in pre-licensure studies, it is hard to expect the 
general public to have confidence in a new vaccine. Discerning which physicians lack 
confidence in vaccine safety studies and why will help policy makers target educational 
campaigns. Physician confidence in vaccine safety studies should continue to be monitored, 
and reasons for lack of confidence should be explored.
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Table 1
Physicians’ reported level of confidence in pre- and post-licensure vaccine safety studies among pediatricians 
and family physicians administering childhood vaccines in their practice.
Pre-licensure confidence 2007 2011 p-valued
Pediatricians, n (%)a
 A great deal of confidence 120 (34)c 116 (41) 0.38
 Moderate confidence 202 (58) 138 (49)
 A little confidence/No confidence at all   29 (8)   30 (11)
Family physicians, n (%)b
 A great deal of confidence   23 (9)   24 (13) 0.22
 Moderate confidence 142 (56) 107 (57)
 A little confidence/no confidence at all   87 (35)   58 (31)
Post-licensure confidence
Pediatricians, n (%)
 A great deal of confidence 160 (45) 168 (59) 0.002
 Moderate confidence 171 (49) 101 (36)
 A little confidence/no confidence at all   22 (6)   15 (5)
Family physicians, n (%)
 A great deal of confidence   49 (20)   57 (30) 0.007
 Moderate confidence 165 (66) 113 (60)
 A little confidence/no confidence at all   37 (15)   19 (10)
Portions of the 2007 data for family physicians were previously used as part of a multivariable analysis of factors associated with routinely offering 
rotavirus vaccine to eligible infants (Kempe A, Patel MM, Daley MF, Crane LA, Beaty B, Stokley S et al. Adoption of Rotavirus Vaccination by 
Pediatricians and Family Medicine Physicians in the United States. Pediatrics 2009; 124(5)).
Data from the US national physicians’ survey administered 08/2007–10/2007 and 11/2010–01/2011.
a
For pediatricians, n=360 for 2007 survey and n=274 for 2011 survey.
b
For family physicians, n=263 for 2007 survey and n=189 for 2011 survey; family physicians who reported not seeing infants under 6 months were 
excluded.
c
Some numbers may not sum to group totals due to missing answers and some percentages may not add to 100 due to rounding.
d
Comparison is Mantel–Haenszel χ2 test, 2007 vs. 2011.
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